KPV and LL-37 Interaction
KPV and LL-37 have a synergistic interaction with 95% confidence. Complementary antimicrobial and healing effects. Both compounds affect the blood vessels, so monitoring these systems is recommended.
Compound Profiles
KPV
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling. Reduces pro-inflammatory cytokines (TNF-α, IL-6) without causing immunosuppression like steroids.
View full profileLL-37
Human Cathelicidin | Antimicrobial Peptide
Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..
View full profileCombined Organ Load
Frequently Asked Questions
Can I take KPV with LL-37?
Yes, KPV and LL-37 can generally be taken together. Complementary antimicrobial and healing effects.
Is KPV and LL-37 safe together?
Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between KPV and LL-37?
Complementary antimicrobial and healing effects. This assessment has 95% confidence and is based on documented research data.
How should I time KPV and LL-37?
KPV has a half-life of 1-2 hours and LL-37 has a half-life of Short (rapid proteolytic degradation). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.